making accurate, valuable information accessible
Well, frankly, not much.
Medical education (med ed) agencies are virtually the same as medical communications agencies, and at Rx Communications we call ourselves by either term. Some med ed agencies focus on delivering marketing & training materials that help pharmaceutical and medical devices companies educate patients, subscribers and payers not only about their product but also about disease awareness. Other medical communications agencies may concentrate on developing the scientific platform for key opinion leaders (KOLs), which would include scientific and clinical journal publications as well as congress materials. Yet others may focus on clinical trial documents and regulatory materials. With our range of writer expertise and superb project management, we can manage it all. We deliver quality clinical and pre-clinical study protocols, reports and investigator materials, alongside medical communications and medical education in whatever format our clients want.
Our only criterion is that the project in question has a valid scientific foundation so that whatever we do adds to an evidence base that supports and encourages good healthcare information and decision-making.
EBM or evidence-based medicine is vital for improving healthcare. And so much of it now incorporates the use of big data and outcomes research. The sheer volume of data can make the job of communication a tricky one – data selection is vital but must not bias the evidence. This is where publications planning and communications strategy comes in.
Initially, the focus should be on understanding how, when and why healthcare decisions are made – and of course, who makes them. By healthcare decisions we mean decisions right from the top, e.g. government policy, regulatory authorities, formulary committees etc. right down to the selection of a particular wound covering made by a nurse, a prescription by a subscriber, or an OTC (over the counter) healthcare product decision made by a patient/consumer.
A medical communications agency worth its salt should help find the answers to these questions, take the evidence available, perform the necessary competitor and benchmarking analyses and be able to come up with a publications plan and/or communications strategy that fulfils these criteria for the decisionmakers that are most important to the client.
Of course, to collect ALL the evidence necessary to fulfil every audience/decisionmaker in every country is an impossible task. And hugely expensive. So the next questions become: Who are the most important target audiences, and when, how and what do they need to know/understand to make healthcare decisions?
Sadly, the confidential nature of our work means that our client testimonials are anonymous, but we still think it’s important for you to know what they think of us anyway!
In the traditional clinical trial model, patients are enrolled in a clinical trial and then the effects of a treatment are assessed. However, this approach can be time-consuming and costly. Cytel’s […]
Veta Health sponsored research into how digital disease management tools could reduce hospital readmissions for patients with Congestive Heart Failure (CHF). Researchers noted that upon adoption of […]
An on-demand webinar offered by Cytel details how information borrowing in basket trial studies can offer valuable insight. Basket trials can often lead to accelerated approval of oncology drugs as a […]
In 2020, lung cancer was the second most commonly diagnosed cancer type globally and accounted for the most cancer deaths. Although other risk factors for lung cancer include exposure to…
Getting a daily dose of Vitamin D from the sun helps to build strong bones, teeth and muscles. But as we all know, there’s a fine balance between safe sun…
Keywords play a vital role when creating the most effective congress abstract. So be concise.
Scientific posters can be a wonderful way to communicate data and spark conversations. They are also an excellent tool to get word out about new findings or trials before the…
Slide decks or slide sets are preferred by pharma, clinical and biotech companies as an excellent tool, mainly for: Investor outreach (investor pitch deck) Product marketing presentations Product training (internal…
The original abstract is the initial presentation and encore abstract is reproduced data of an original abstract with minor changes in line with Congress guidelines, which can communicate the same…
Get our Health Outcomes Communicator direct to your inbox – sign-up now!
Please note: we will not pass your details on to any third-parties. View our Privacy Policy here.
